Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K954759
    Device Name
    FLOWMATE LTE
    Date Cleared
    1996-04-12

    (178 days)

    Product Code
    Regulation Number
    868.1840
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K863953/A, K900673, K911143

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Intended use for the Flowmate LTE is for Pulmonary Function Testing (measuring a person's ability to move air into and out of their lungs). The volume and flow rates measured for the entire effort and then reported as numerical results with a printout of the effort if selected.

    Device Description

    Flow sensing pneumotach and base that measures differential pressure as air passes through it (the same principle as the Flowmate, PC Flow +, Renaissance, and Flash devices)
    Compact design molded from high impact UL rated ABS plastic. rechargeable Ni-Cad batteries for portable operation,
    Automatic calculations of test results, and best test selection based on ATS criteria
    Testing capabilities include; FVC, FEV1, FEV3, FEV1/FVC%, FEF.2-1.2, FEF25-75%, FEF75-85, PEF, FEF50, FIVC, FEF50/FIF50, PIF, MVV, Methacholine Challenge, and Lung Age
    Testing Capabilities: Capacity 10 Liters
    Volume Accuracy +/- 3% Max. Flow Rate +/- 16 L/s
    Back Pressure Less than 1.5 cm H2O
    Population Predicted Normals included: Composite Knudson Crapo (ITS) ECCS HSU
    Customization allows user to change report format, input temperature and barometric readings, and select printer driver for printer being used
    Reports printed on standard 8 1/2 " x 11" paper
    Field calibration with a 1 to 9 Liter calibration syringe
    Cross-contamination control via external filter system

    AI/ML Overview

    Here's an analysis of the provided text regarding the acceptance criteria and study for the Flowmate LTE device:

    Acceptance Criteria and Device Performance

    Acceptance CriteriaReported Device Performance
    Volume Accuracy+/- 3%
    Max. Flow Rate+/- 16 L/s
    Back PressureLess than 1.5 cm H2O
    FVC AccuracyExceeded ATS recommendations at 23 out of 24 waveforms. At waveform #17 (which exceeds the device's 15-second recording limit), accuracy was -1.8% at the 15-second mark, which is within ATS recommendations.
    FEV1 AccuracyExceeded ATS recommendations at 23 out of 24 waveforms.
    FEF 25-75 AccuracyExceeded ATS recommendations at 23 out of 24 waveforms.
    PEF AccuracyExceeded ATS recommendations at 23 out of 24 waveforms.
    MVV AccuracyAcceptable results compared with ATS criteria for accuracy and precision to delivered values.

    Study Information

    2. Sample size used for the test set and the data provenance:

    • Test Set Sample Size:
      • Waveform Performance Testing: 24 waveforms were used.
      • MVV Testing: A 2-liter volume at flow rates from 40 to 245 L/M was used. The number of specific tests or readings performed is not specified, but it refers to a range of flow rates.
    • Data Provenance: The document does not explicitly state the country of origin or if the data was retrospective or prospective. The testing appears to be laboratory-based performance testing rather than human clinical data.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    • The ground truth for the test set (waveforms and MVV) was established based on "ATS recommendations" and "delivered values" from a 2-liter calibration syringe. No human experts are mentioned as directly establishing the ground truth for these performance tests.

    4. Adjudication method for the test set:

    • Not applicable, as the ground truth was based on pre-defined standards (ATS recommendations) and objective measurements from a calibration syringe, not on human interpretation requiring adjudication.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    • No, a multi-reader multi-case comparative effectiveness study was not done. This device is a diagnostic spirometer, which directly measures physiological parameters, not an AI-powered image analysis or diagnostic support tool that would typically involve human readers.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

    • Yes, the performance testing described for the Flowmate LTE is a standalone performance study. The device's measurements (volume, flow rates) are directly compared against established standards (ATS recommendations) and known delivered values (from a calibration syringe). There is no "human-in-the-loop" aspect to the performance evaluation itself, though the device is intended for human use.

    7. The type of ground truth used:

    • The ground truth used was based on expert consensus standards (ATS recommendations for FVC, FEV1, FEF 25-75, PEF, MVV accuracy and precision) and objective measurements from a calibrated device (a 1 to 9 Liter calibration syringe for field calibration, and a 2-liter volume for MVV testing).

    8. The sample size for the training set:

    • The document does not describe a "training set" in the context of machine learning or AI. This device appears to be a hardware-based medical device with integrated software for calculations, not a learning-based algorithm that requires a training set.

    9. How the ground truth for the training set was established:

    • Not applicable, as there is no mention of a training set for a machine learning algorithm.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1